Balance Sheet
Accounts PayablesAccumulated ExpensesCash & Current InvestmentsCash & EquivalentsCurrent AssetsCurrent TaxesGoodwill & IntangiblesInventoryLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsPayablesProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zhengye Biotechnology Holding (ZYBT) Retained Earnings: 2023-2024

Historic Retained Earnings for Zhengye Biotechnology Holding (ZYBT) over the last 2 years, with Dec 2024 value amounting to $6.7 million.

  • Zhengye Biotechnology Holding's Retained Earnings was N/A to $3.7 million in Q2 2025 from the same period last year, while for Jun 2025 it was $3.7 million, marking a year-over-year change of. This contributed to the annual value of $6.7 million for FY2024, which is 23.39% up from last year.
  • Latest data reveals that Zhengye Biotechnology Holding reported Retained Earnings of $6.7 million as of FY2024, which was up 23.39% from $5.4 million recorded in FY2023.
  • Zhengye Biotechnology Holding's 5-year Retained Earnings high stood at $6.7 million for FY2024, and its period low was $5.4 million during FY2023.
  • Its 2-year average for Retained Earnings is $6.1 million, with a median of $6.1 million in 2023.
  • Data for Zhengye Biotechnology Holding's Retained Earnings shows a peak YoY climbed of 23.39% (in 2024) over the last 5 years.
  • Over the past 2 years, Zhengye Biotechnology Holding's Retained Earnings (Yearly) stood at $5.4 million in 2023, then climbed by 23.39% to $6.7 million in 2024.